![Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/91991eee-97f9-49db-a7c6-2d3849e5c67e/e007982fig02.jpg)
Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions
![Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents | Circulation: Cardiovascular Interventions Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/a0a07a37-a513-45cd-822a-c596a141c7bc/e006243fig02.gif)
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents | Circulation: Cardiovascular Interventions
![Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis | Circulation: Cardiovascular Interventions Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/762b4ca7-58f9-42ce-917f-30633c127a8e/e007822fig04.jpg)
Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis | Circulation: Cardiovascular Interventions
![TCT-68. Does IVUS Reduce Stent Thrombosis with DES? Two-year results from the prospective, multicenter ADAPT-DES study | tctmd.com TCT-68. Does IVUS Reduce Stent Thrombosis with DES? Two-year results from the prospective, multicenter ADAPT-DES study | tctmd.com](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/styles/large_slide_teaser/public/2013-10/121499.png?itok=laqEzUGT)
TCT-68. Does IVUS Reduce Stent Thrombosis with DES? Two-year results from the prospective, multicenter ADAPT-DES study | tctmd.com
![Effect of Intravascular Ultrasound–Guided Drug-Eluting Stent Implantation: 5-Year Follow-Up of the IVUS-XPL Randomized Trial - ScienceDirect Effect of Intravascular Ultrasound–Guided Drug-Eluting Stent Implantation: 5-Year Follow-Up of the IVUS-XPL Randomized Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879819320199-fx1.jpg)
Effect of Intravascular Ultrasound–Guided Drug-Eluting Stent Implantation: 5-Year Follow-Up of the IVUS-XPL Randomized Trial - ScienceDirect
![ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download](https://images.slideplayer.com/26/8755382/slides/slide_5.jpg)
ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download
![Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES | JACC: Cardiovascular Interventions Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES | JACC: Cardiovascular Interventions](https://www.jacc.org/cms/asset/1b670a11-a9a8-4eea-b373-f3288688da03/fx1.jpg)
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES | JACC: Cardiovascular Interventions
![The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer - Ulrike Nitz, The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer - Ulrike Nitz,](https://journals.sagepub.com/cms/10.1177/1758835920973130/asset/images/large/10.1177_1758835920973130-fig1.jpeg)
The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer - Ulrike Nitz,
![JCM | Free Full-Text | Revascularization and Medical Therapy for Chronic Coronary Syndromes: Lessons Learnt from Recent Trials, a Literature Review JCM | Free Full-Text | Revascularization and Medical Therapy for Chronic Coronary Syndromes: Lessons Learnt from Recent Trials, a Literature Review](https://www.mdpi.com/jcm/jcm-12-02833/article_deploy/html/images/jcm-12-02833-g001.png)
JCM | Free Full-Text | Revascularization and Medical Therapy for Chronic Coronary Syndromes: Lessons Learnt from Recent Trials, a Literature Review
![Trials of DAPT after PCI. Trial result is reported according to whether... | Download Scientific Diagram Trials of DAPT after PCI. Trial result is reported according to whether... | Download Scientific Diagram](https://www.researchgate.net/publication/319322703/figure/fig1/AS:757852222271489@1557697458489/Trials-of-DAPT-after-PCI-Trial-result-is-reported-according-to-whether-the-hypothesis.png)
Trials of DAPT after PCI. Trial result is reported according to whether... | Download Scientific Diagram
![Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES | JACC: Cardiovascular Interventions Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES | JACC: Cardiovascular Interventions](https://www.jacc.org/cms/asset/60e8d290-09ec-489c-adb8-460a75160e81/gr3.jpg)
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES | JACC: Cardiovascular Interventions
![Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES | JACC: Cardiovascular Interventions Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES | JACC: Cardiovascular Interventions](https://www.jacc.org/cms/asset/dc41b68e-c1d0-4d96-9f31-1be3d2e4f614/fx1.jpg)
Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES | JACC: Cardiovascular Interventions
![3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation - ScienceDirect 3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879820320203-fx1.jpg)
3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation - ScienceDirect
![Randomized comparison of transradial and transfemoral approach for carotid artery stenting | tctmd.com Randomized comparison of transradial and transfemoral approach for carotid artery stenting | tctmd.com](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/styles/large_slide_teaser/public/2013-10/122916.png?itok=0Y9SCZM4)
Randomized comparison of transradial and transfemoral approach for carotid artery stenting | tctmd.com
![De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis | Nature Reviews Cardiology De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis | Nature Reviews Cardiology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41569-023-00901-2/MediaObjects/41569_2023_901_Fig1_HTML.png)
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis | Nature Reviews Cardiology
![TCT-50. Angiographic Predictor of 2-Year Stent Thrombosis in Patients Receiving Drug-eluting Stents: Insights from the ADAPT-DES Study | tctmd.com TCT-50. Angiographic Predictor of 2-Year Stent Thrombosis in Patients Receiving Drug-eluting Stents: Insights from the ADAPT-DES Study | tctmd.com](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/styles/large_slide_teaser/public/2013-10/122682.png?itok=kijO6CuQ)
TCT-50. Angiographic Predictor of 2-Year Stent Thrombosis in Patients Receiving Drug-eluting Stents: Insights from the ADAPT-DES Study | tctmd.com
![Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES - ScienceDirect Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879821009419-fx1.jpg)
Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES - ScienceDirect
![ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download](https://images.slideplayer.com/26/8755382/slides/slide_7.jpg)
ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download
![Correlates of High Platelet Reactivity on Clopidogrel in 8,533 Patients: An ADAPT-DES Substudy | tctmd.com Correlates of High Platelet Reactivity on Clopidogrel in 8,533 Patients: An ADAPT-DES Substudy | tctmd.com](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/styles/large_slide_teaser/public/2013-10/122905.png?itok=FfAJKGPF)
Correlates of High Platelet Reactivity on Clopidogrel in 8,533 Patients: An ADAPT-DES Substudy | tctmd.com
![ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download ADAPT-DES One-Year Results Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents A Large-Scale, Multicenter, Prospective, Observational Study. - ppt download](https://slideplayer.com/8755382/26/images/slide_1.jpg)